Loading…
Effect of statins in preventing hospitalizations for infections: A population study
Purpose To investigate whether the hospitalization rate for bacterial infections was modified by statin therapy in a population retrospectively followed up, over years 2011 to 2015. Methods By using administrative databases, the 5‐year hospitalization rate due to bacterial infections in population l...
Saved in:
Published in: | Pharmacoepidemiology and drug safety 2018-08, Vol.27 (8), p.878-884 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43 |
---|---|
cites | cdi_FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43 |
container_end_page | 884 |
container_issue | 8 |
container_start_page | 878 |
container_title | Pharmacoepidemiology and drug safety |
container_volume | 27 |
creator | Policardo, Laura Seghieri, Giuseppe Gualdani, Elisa Franconi, Flavia |
description | Purpose
To investigate whether the hospitalization rate for bacterial infections was modified by statin therapy in a population retrospectively followed up, over years 2011 to 2015.
Methods
By using administrative databases, the 5‐year hospitalization rate due to bacterial infections in population living in Tuscany, Italy exposed to statin therapy (n = 52,049) was stratified by 5 prescribed daily doses classes (0%‐20%, 20%‐50%, 50%‐80%, 80%‐100%, ≥100% of DDD) and subsequently compared with that of a population of untreated individuals (n = 3 300 ,675), matched through a propensity score accounting for all available covariates potentially able to modulate risk of infections such as age, gender, previous hospitalizations for infections, cardiovascular events, previous co‐morbidities, diabetes, as well as general practitioners' proactive behaviour of care delivery according to current guidelines.
Results
Unmatched individuals of each treatment‐class had significantly more hospitalizations than controls, while matched treated people, apart from those in class 0% to 20%, had a decrease of hospitalizations, as large as the increase in prescribed drug. Statin effect in reducing hospitalizations translated into a number needed to treat (NNT) ranging across treatment strata from 102 to 54.
Conclusions
Compliance to statin prescribed daily doses above the threshold 20% of DDD, along a 5‐year follow‐up, prevented hospitalizations due to infectious diseases in a large unselected population, after adjusting for covariates able to modulate baseline risk of infections. The NNTs to avoid 1 hospitalization for infections resulted on average not too dissimilar from a value lying between the 95% CI of NNTs previously found for primary prevention of 1 incident coronary ischemic event (72 to 119). |
doi_str_mv | 10.1002/pds.4557 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2046606503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2046606503</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43</originalsourceid><addsrcrecordid>eNp1kF1LwzAUhoMobk7BXyAFb7yppknTNN4NnR8wUJheh6xJtKNratIq89d7uk0Fwauc8D55yHkROk7weYIxuWh0OE8Z4ztomGAh4gTm3X5mNM5ZJgboIIQFxpCJdB8NiMhxzjAdotnEWlO0kbNRaFVb1iEq66jx5t3UcHuJXl1oylZV5SekDmLrPCD9o_56GY2jxjVdtU7B0enVIdqzqgrmaHuO0PPN5OnqLp4-3N5fjadxQVPBY8GLwgiSFRTbOSNcMZ4xTjijiTGZMjlPBcFWM2a00oxQzfOcaApbAaJSOkJnG2_j3VtnQiuXZShMVanauC5IgtMswxnsCejpH3ThOl_D74DKE0EFT_mvsPAuBG-sbHy5VH4lEyz7oiUULfuiAT3ZCrv50ugf8LtZAOIN8FFWZvWvSD5ez9bCLw1BhjE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2081939747</pqid></control><display><type>article</type><title>Effect of statins in preventing hospitalizations for infections: A population study</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Policardo, Laura ; Seghieri, Giuseppe ; Gualdani, Elisa ; Franconi, Flavia</creator><creatorcontrib>Policardo, Laura ; Seghieri, Giuseppe ; Gualdani, Elisa ; Franconi, Flavia</creatorcontrib><description>Purpose
To investigate whether the hospitalization rate for bacterial infections was modified by statin therapy in a population retrospectively followed up, over years 2011 to 2015.
Methods
By using administrative databases, the 5‐year hospitalization rate due to bacterial infections in population living in Tuscany, Italy exposed to statin therapy (n = 52,049) was stratified by 5 prescribed daily doses classes (0%‐20%, 20%‐50%, 50%‐80%, 80%‐100%, ≥100% of DDD) and subsequently compared with that of a population of untreated individuals (n = 3 300 ,675), matched through a propensity score accounting for all available covariates potentially able to modulate risk of infections such as age, gender, previous hospitalizations for infections, cardiovascular events, previous co‐morbidities, diabetes, as well as general practitioners' proactive behaviour of care delivery according to current guidelines.
Results
Unmatched individuals of each treatment‐class had significantly more hospitalizations than controls, while matched treated people, apart from those in class 0% to 20%, had a decrease of hospitalizations, as large as the increase in prescribed drug. Statin effect in reducing hospitalizations translated into a number needed to treat (NNT) ranging across treatment strata from 102 to 54.
Conclusions
Compliance to statin prescribed daily doses above the threshold 20% of DDD, along a 5‐year follow‐up, prevented hospitalizations due to infectious diseases in a large unselected population, after adjusting for covariates able to modulate baseline risk of infections. The NNTs to avoid 1 hospitalization for infections resulted on average not too dissimilar from a value lying between the 95% CI of NNTs previously found for primary prevention of 1 incident coronary ischemic event (72 to 119).</description><identifier>ISSN: 1053-8569</identifier><identifier>EISSN: 1099-1557</identifier><identifier>DOI: 10.1002/pds.4557</identifier><identifier>PMID: 29808503</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Bacterial infections ; Diabetes mellitus ; Health risks ; hospitalizations ; Infections ; Infectious diseases ; Ischemia ; number needed to treat ; pharmacoepidemiology ; Population ; Population studies ; population study ; propensity score ; Statins</subject><ispartof>Pharmacoepidemiology and drug safety, 2018-08, Vol.27 (8), p.878-884</ispartof><rights>Copyright © 2018 John Wiley & Sons, Ltd.</rights><rights>2018 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43</citedby><cites>FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43</cites><orcidid>0000-0002-7599-4455</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29808503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Policardo, Laura</creatorcontrib><creatorcontrib>Seghieri, Giuseppe</creatorcontrib><creatorcontrib>Gualdani, Elisa</creatorcontrib><creatorcontrib>Franconi, Flavia</creatorcontrib><title>Effect of statins in preventing hospitalizations for infections: A population study</title><title>Pharmacoepidemiology and drug safety</title><addtitle>Pharmacoepidemiol Drug Saf</addtitle><description>Purpose
To investigate whether the hospitalization rate for bacterial infections was modified by statin therapy in a population retrospectively followed up, over years 2011 to 2015.
Methods
By using administrative databases, the 5‐year hospitalization rate due to bacterial infections in population living in Tuscany, Italy exposed to statin therapy (n = 52,049) was stratified by 5 prescribed daily doses classes (0%‐20%, 20%‐50%, 50%‐80%, 80%‐100%, ≥100% of DDD) and subsequently compared with that of a population of untreated individuals (n = 3 300 ,675), matched through a propensity score accounting for all available covariates potentially able to modulate risk of infections such as age, gender, previous hospitalizations for infections, cardiovascular events, previous co‐morbidities, diabetes, as well as general practitioners' proactive behaviour of care delivery according to current guidelines.
Results
Unmatched individuals of each treatment‐class had significantly more hospitalizations than controls, while matched treated people, apart from those in class 0% to 20%, had a decrease of hospitalizations, as large as the increase in prescribed drug. Statin effect in reducing hospitalizations translated into a number needed to treat (NNT) ranging across treatment strata from 102 to 54.
Conclusions
Compliance to statin prescribed daily doses above the threshold 20% of DDD, along a 5‐year follow‐up, prevented hospitalizations due to infectious diseases in a large unselected population, after adjusting for covariates able to modulate baseline risk of infections. The NNTs to avoid 1 hospitalization for infections resulted on average not too dissimilar from a value lying between the 95% CI of NNTs previously found for primary prevention of 1 incident coronary ischemic event (72 to 119).</description><subject>Bacterial infections</subject><subject>Diabetes mellitus</subject><subject>Health risks</subject><subject>hospitalizations</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Ischemia</subject><subject>number needed to treat</subject><subject>pharmacoepidemiology</subject><subject>Population</subject><subject>Population studies</subject><subject>population study</subject><subject>propensity score</subject><subject>Statins</subject><issn>1053-8569</issn><issn>1099-1557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kF1LwzAUhoMobk7BXyAFb7yppknTNN4NnR8wUJheh6xJtKNratIq89d7uk0Fwauc8D55yHkROk7weYIxuWh0OE8Z4ztomGAh4gTm3X5mNM5ZJgboIIQFxpCJdB8NiMhxzjAdotnEWlO0kbNRaFVb1iEq66jx5t3UcHuJXl1oylZV5SekDmLrPCD9o_56GY2jxjVdtU7B0enVIdqzqgrmaHuO0PPN5OnqLp4-3N5fjadxQVPBY8GLwgiSFRTbOSNcMZ4xTjijiTGZMjlPBcFWM2a00oxQzfOcaApbAaJSOkJnG2_j3VtnQiuXZShMVanauC5IgtMswxnsCejpH3ThOl_D74DKE0EFT_mvsPAuBG-sbHy5VH4lEyz7oiUULfuiAT3ZCrv50ugf8LtZAOIN8FFWZvWvSD5ez9bCLw1BhjE</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Policardo, Laura</creator><creator>Seghieri, Giuseppe</creator><creator>Gualdani, Elisa</creator><creator>Franconi, Flavia</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7599-4455</orcidid></search><sort><creationdate>201808</creationdate><title>Effect of statins in preventing hospitalizations for infections: A population study</title><author>Policardo, Laura ; Seghieri, Giuseppe ; Gualdani, Elisa ; Franconi, Flavia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Bacterial infections</topic><topic>Diabetes mellitus</topic><topic>Health risks</topic><topic>hospitalizations</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Ischemia</topic><topic>number needed to treat</topic><topic>pharmacoepidemiology</topic><topic>Population</topic><topic>Population studies</topic><topic>population study</topic><topic>propensity score</topic><topic>Statins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Policardo, Laura</creatorcontrib><creatorcontrib>Seghieri, Giuseppe</creatorcontrib><creatorcontrib>Gualdani, Elisa</creatorcontrib><creatorcontrib>Franconi, Flavia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacoepidemiology and drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Policardo, Laura</au><au>Seghieri, Giuseppe</au><au>Gualdani, Elisa</au><au>Franconi, Flavia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of statins in preventing hospitalizations for infections: A population study</atitle><jtitle>Pharmacoepidemiology and drug safety</jtitle><addtitle>Pharmacoepidemiol Drug Saf</addtitle><date>2018-08</date><risdate>2018</risdate><volume>27</volume><issue>8</issue><spage>878</spage><epage>884</epage><pages>878-884</pages><issn>1053-8569</issn><eissn>1099-1557</eissn><abstract>Purpose
To investigate whether the hospitalization rate for bacterial infections was modified by statin therapy in a population retrospectively followed up, over years 2011 to 2015.
Methods
By using administrative databases, the 5‐year hospitalization rate due to bacterial infections in population living in Tuscany, Italy exposed to statin therapy (n = 52,049) was stratified by 5 prescribed daily doses classes (0%‐20%, 20%‐50%, 50%‐80%, 80%‐100%, ≥100% of DDD) and subsequently compared with that of a population of untreated individuals (n = 3 300 ,675), matched through a propensity score accounting for all available covariates potentially able to modulate risk of infections such as age, gender, previous hospitalizations for infections, cardiovascular events, previous co‐morbidities, diabetes, as well as general practitioners' proactive behaviour of care delivery according to current guidelines.
Results
Unmatched individuals of each treatment‐class had significantly more hospitalizations than controls, while matched treated people, apart from those in class 0% to 20%, had a decrease of hospitalizations, as large as the increase in prescribed drug. Statin effect in reducing hospitalizations translated into a number needed to treat (NNT) ranging across treatment strata from 102 to 54.
Conclusions
Compliance to statin prescribed daily doses above the threshold 20% of DDD, along a 5‐year follow‐up, prevented hospitalizations due to infectious diseases in a large unselected population, after adjusting for covariates able to modulate baseline risk of infections. The NNTs to avoid 1 hospitalization for infections resulted on average not too dissimilar from a value lying between the 95% CI of NNTs previously found for primary prevention of 1 incident coronary ischemic event (72 to 119).</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29808503</pmid><doi>10.1002/pds.4557</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-7599-4455</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1053-8569 |
ispartof | Pharmacoepidemiology and drug safety, 2018-08, Vol.27 (8), p.878-884 |
issn | 1053-8569 1099-1557 |
language | eng |
recordid | cdi_proquest_miscellaneous_2046606503 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Bacterial infections Diabetes mellitus Health risks hospitalizations Infections Infectious diseases Ischemia number needed to treat pharmacoepidemiology Population Population studies population study propensity score Statins |
title | Effect of statins in preventing hospitalizations for infections: A population study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T00%3A35%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20statins%20in%20preventing%20hospitalizations%20for%20infections:%20A%20population%20study&rft.jtitle=Pharmacoepidemiology%20and%20drug%20safety&rft.au=Policardo,%20Laura&rft.date=2018-08&rft.volume=27&rft.issue=8&rft.spage=878&rft.epage=884&rft.pages=878-884&rft.issn=1053-8569&rft.eissn=1099-1557&rft_id=info:doi/10.1002/pds.4557&rft_dat=%3Cproquest_cross%3E2046606503%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3497-97cce926c30fb527a5765727531ee6ae874920fd55edad523d7882d3105531a43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2081939747&rft_id=info:pmid/29808503&rfr_iscdi=true |